FTC reviewing UnitedHealth, LHC deal for “potential vertical harm”

The Federal Trade Commission is reviewing UnitedHealth Group Inc.'s planned purchase of home health firm LHC Group under a "potential vertical harm theory," reports Becker’s Payer Issues. The federal agency is expected to conclude gathering information about the proposal soon, and UnitedHealth has hired an attorney that represented it during the antitrust trial over its Change Healthcare purchase last year.